| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2014 | Ring fusion strategy for the synthesis of anthra[2,3-d ]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents | Chen C.-L.; Liu F.-L.; Lee C.-C.; Chen T.-C.; Chang W.-W.; JIH-HWA GUH ; Ahmed Ali A.A.; Chang D.-M.; Huang H.-S. | European Journal of Medicinal Chemistry | 19 | 17 | |
| 2011 | SLC25A13 gene mutations in Taiwanese patients with non-viralhepatocellular carcinoma | Chang K.-W.; HUEY-LING CHEN ; YIN-HSIU CHIEN ; Chen T.-C.; Yeh C.-T. | Molecular Genetics and Metabolism | 16 | 17 | |
| 2012 | Spontaneous inflammatory pain model from a mouse line with N-ethyl-N-nitrosourea mutagenesis | Chen T.-C.; Wu J.J.-S.; Chang W.-P.; PING-NING HSU ; SUNG-TSANG HSIEH ; Shyu B.-C. | Journal of Biomedical Science | 6 | 6 | |
| 2013 | Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents | Chen T.-C.; Yu D.-S.; Huang K.-F.; Fu Y.-C.; Lee C.-C.; Chen C.-L.; Huang F.-C.; Hsieh H.-H.; JING-JER LIN ; Huang H.-S. | European Journal of Medicinal Chemistry | 26 | 24 | |
| 2013 | Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology | Chen C.-L.; Chang D.-M.; Chen T.-C.; Lee C.-C.; Hsieh H.-H.; Huang F.-C.; Huang K.-F.; JIH-HWA GUH ; JING-JER LIN ; Huang H.-S. | European Journal of Medicinal Chemistry | 35 | 34 | |
| 2021 | The structure–function correlation analysed by OCT and full field ERG in typical and pericentral subtypes of retinitis pigmentosa | Huang C.-W.; Yang J.-J.; CHANG-HAO YANG ; CHUNG-MAY YANG ; FUNG-RONG HU ; TZYY-CHANG HO ; Chen T.-C. | Scientific Reports | 1 | 1 | |
| 2019 | Synthesis and biological evaluation of anthra[1,9-cd]pyrazol-6(2H)-one scaffold derivatives as potential anticancer agents | Chen T.-C.; JIH-HWA GUH ; Hsu H.-W.; Chen C.-L.; Lee C.-C.; Wu C.-L.; Lee Y.-R.; JING-JER LIN ; Yu D.-S.; Huang H.-S. | Arabian Journal of Chemistry | 7 | 7 | |
| 2012 | Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives | Lee C.-C.; Huang K.-F.; Lin P.-Y.; Huang F.-C.; Chen C.-L.; Chen T.-C.; JIH-HWA GUH ; JING-JER LIN ; Huang H.-S. | European Journal of Medicinal Chemistry | 24 | 22 | |
| 2009 | Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[ 1,2-d]imidazole-6,11 -dione homologues | Huang H.-S.; Chen T.-C.; Chen R.-H.; Huang K.-F.; Huang F.-C.; Jhan J.-R.; Chen C.-L.; Lee C.-C.; Lo Y.; JING-JER LIN | Bioorganic and Medicinal Chemistry | 54 | 51 | |
| 2012 | Synthesis, telomerase evaluation and anti-proliferative studies on various series of diaminoanthraquinone-lkinked aminoacyl residue derivatives | Huang F.-C.; Huang K.-F.; Chen R.-H.; Wu J.-E.; Chen T.-C.; Chen C.-L.; Lee C.-C.; Chen J.-Y.; JING-JER LIN ; Huang H.-S. | Archiv der Pharmazie | 8 | 8 | |
| 2022 | Treat-and-Extend vs. Pro Re Nata Regimen of Ranibizumab for Diabetic Macular Edema—A Two-Year Matched Comparative Study | Lai T.-T.; Chen T.-C.; CHANG-HAO YANG ; CHUNG-MAY YANG ; TZYY-CHANG HO ; Hsieh Y.-T. | Frontiers in Medicine | 3 | 3 | |
| 2015 | Two novel motifs of watermelon silver mottle virus NSs protein are responsible for RNA silencing suppression and pathogenicity | Huang C.-H.; Hsiao W.-R.; Huang C.-W.; Chen K.-C.; Lin S.-S.; Chen T.-C.; Raja J.A.J.; Wu H.-W.; SHIH-SHUN LIN ; SHIH-SHUN LIN | PLoS ONE | 12 | 11 | |
| 2016 | Uterine sarcoma Part I—Uterine leiomyosarcoma: The Topic Advisory Group systematic review | Wen K.-C.; Horng H.-C.; Wang P.-H.; Chen Y.-J.; Yen M.-S.; Ng H.-T.; Chang Y.-H.; Chang Y.; Chao H.-T.; Chao K.-C.; Chuang C.-M.; Ho C.-H.; Huang C.-Y.; Hung Z.-C.; Jiang L.-Y.; Lau H.-Y.; Li H.-Y.; Lin C.-Y.; Liu C.-H.; Sun P.-L.; Twu N.-F.; Wu H.-H.; Yu H.-C.; Ju F.-Y.; Tsai C.-P.; Chang W.-H.; Hsu Y.-M.; Lee N.-R.; Chen C.-Y.; TING-CHEN CHANG ; WEN-CHUN CHANG ; Chen C.-H.; RUEY-JIEN CHEN ; SONG-NAN CHOW ; YIH-RON LIEN ; BOR-CHING SHEU ; PAO-LING TORNG ; Yen M.-L.; Lee W.-L.; Wang K.-C.; Chang C.-L.; Chen C.-P.; Chen J.-R.; Chen T.-C.; Huang J.-P.; Huang M.-C.; Wang Y.-L.; Chang C.-C.; Liu J.-Y.; Su H.-Y.; Wang Y.-C.; Yu M.-H.; Huang L.-W.; Seow K.-M.; Lai T.-H.; Lee F.-K.; Chen C.-H.; Huang B.-S.; Hsiao S.-M.; Sun H.-D.; Wu W.-Y.; Teng S.-W.; Chen K.-H.; Hung J.-H.; Lai H.-C.; Yuan C.-C.; Hsieh C.-H.; Wang C.-J.; Chang S.-J.; Hung M.-J.; Hsu S.-T.; Ke Y.-M.; Lu C.-H.; Sun L.; WEN-CHUN CHANG ; Hung Y.-C.; Lin W.-C.; Wang P.-H.; Chen T.-H.; Li Y.-T.; Wu M.-H.; Huang K.-F.; Fu H.-C.; Chen S.-N.; Chiang A.-J.; Li J.-Y.; Lin L.-T.; Tsai H.-W.; Tsui K.-H. | Taiwanese Journal of Obstetrics and Gynecology | 26 | 27 | |
| 1997 | Valtrac?-secured intracolonic bypass device: An experimental study | Chen T.-C.; Yang M.-J.; Chen S.-R.; Chang C.-P.; Chi C.-H.; CHAU-HWA CHI | Diseases of the Colon and Rectum | 13 | 11 | |
| 2014 | Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin | Chen M.-Y.; CHEN-HUA LIU ; Chen T.-C.; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 8 | 7 | |
| 2009 | Viral and host proteins involved in picornavirus life cycle | JING-YI LIN ; Chen T.-C.; Weng K.-F.; Chang S.-C.; Chen L.-L.; Shih S.-R. | Journal of Biomedical Science | 133 | 124 | |
| 2021 | VLSI Structure-aware Placement for Convolutional Neural Network Accelerator Units | Chou Y; Hsu J.-W; Chen T.-C.; YAO-WEN CHANG | Proceedings - Design Automation Conference | 1 | 0 | |
| 2014 | Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway | Hung T.-H.; Hsu S.-C.; Cheng C.-Y.; Choo K.-B.; Tseng C.-P.; Chen T.-C.; Lan Y.-W.; Huang T.-T.; HSIN-CHIH LAI ; Chen C.-M.; Chong K.-Y. | Oncotarget | 48 | 50 | |
